Antibody Drug Conjugates Market By Drug ( Adcetris, Kadcyla ), By Mechanism of Action ( CD30 Antibodies, HER2 Antibodies ), By Application ( Lymphoma, Breast cancer ), Industry Trends, Estimation & Forecast, 2017 - 2025

May 2018

 Pages: 174

 ERC 9767


Antibody Drug Conjugates Market is expected to generate $3.2 Billion by the end of 2025.

The global antibody drug conjugates market is growing at rapid pace due to increase in number of cancer patients worldwide. However, the market is in infancy stage as only two drugs are being marketed and several ADCs are under last stages of its clinical development. These marketed ADCs target different forms of cancers such as lymphoma and breast cancer. It is predicted that ADCs under development would be able to treat lung cancer, breast cancer, melanoma, and Hodgkin’s lymphoma in the future. Currently, players in the market are taking efforts to develop ADCs that target different domains other than oncology.

Factors such as an increase in consumption in tobacco and alcohol, sedentary lifestyle, and increasing the number of cancer patients across the globe are driving the growth of the market. Moreover, rising awareness among consumer regarding ADC therapy, increasing demand for cost-effective cancer treatment and extensive research and development activities carried by market players boosts market growth. However, high cost involved in the development of ADCs is expected to hinder the growth of the market, whereas, Asia-Pacific shows ample opportunities for ADC developers due to presence of large pool of patients suffering from cancer.

The report provides detailed qualitative and quantitative analysis of the global antibody drug conjugates market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely drugs, mechanism of action, and application in each of the major regions of the world.

Global Antibody Drug Conjugates Market Player Analysis -

The report presents detailed analysis of major players operating in global antibody drug conjugates market. Some of the key players operating in the market are Seattle Genetics Inc., Roche Holding AG, ImmunoGen, Inc., Genentech Inc., Agensys, Inc., Bayer Healthcare Pharmaceuticals, Vaccinex Inc., Concortis Biotherapeutics, Celldex Therapeutics Inc., and Daiichi Sankyo.

Market Segmentation

Global antibody drug conjugates market is segmented based on drugs, mechanism of action, application, and geography. Based on drugs, the market is bifurcated into Adcetris and Kadcyla. Based on mechanism of action, it is classified into CD30 antibodies and HER2 antibodies. Based on application, the market is categorized into lymphoma, breast cancer, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Antibody Drug Conjugates Market Segmentation

By Drug
    • Adcetris
    • Kadcyla

By Mechanism of Action
    • CD30 antibodies
    • HER2 antibodies

By Application
    • Lymphoma
    • Breast cancer
    • Others

By Geography
    • North America
             o U.S.
             o Canada
             o Mexico
    • Europe
             o U.K
             o France
             o Germany
             o Italy
             o Spain
             o Rest of Europe
    • Asia-Pacific
             o Japan
             o China
             o India
             o Rest of Asia-Pacific
    • Rest of the World
             o Middle East
             o Latin America
             o Africa

Antibody Drug Conjugates Market Key Players

• Seattle Genetics Inc.
• Roche Holding AG
• ImmunoGen, Inc.
• Genentech Inc.
• Agensys, Inc.
• Bayer Healthcare Pharmaceuticals
• Vaccinex Inc.
• Concortis Biotherapeutics
• Celldex Therapeutics Inc.
• Daiichi Sankyo

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Antibody Drug Conjugates Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Antibody Drug Conjugates Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!